Table 1 from First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors
收藏数据链接：
官方服务：
资源简介：
Baseline demographics and characteristics.
创建时间：
2025-10-01
